@mike_skane Love me some pens! Especially the V2. I was thinking the other day though, are you concerned about the daily temperature change the peptide goes through? Any concern of it affecting stability?
@OptiNeuroBio@eliterecomp I'm dealing with an API right now. I'm curious to see where their pricing stands amongst other places. Does $54 for 100mg GHK-CU seem to be the norm? Seems high when you can buy it all day long from China for around $5 a vial. You got to pay for compliance, but that much more?
@eliterecomp I bought a $5 hyaluronic serum off Amazon (30ml), added in reconstituted GHK-CU (1ml) and Snap-8 (1ml). I've been on it for a couple days so far, probably wont see results for a few weeks.
Retatrutide is not JUST a drug for weight loss.
It’s also a:
Drug for lowering cholesterol
Drug for lowering blood sugar
Drug for lowering blood pressure
Drug for lowering inflammation
Knee osteoarthritis
Liver fat (NASH)
Obstructive Sleep Apnea
And probably 10 more things.
Monster potential‼️
If you’re taking peptides or just researching them, using AI is a massive help. I use Grok and Claude to tweak and fine tune my cycles. It makes everything so much easier.
@Satoshipeptides It just helps boost your body’s natural testosterone production, unlike TRT completely shutting it down. I’ll probably stay on most of the time with a few weeks off here and there.
"PEPTIDES ARE DEAD"
"RIP PEPTIDES BROS"
"BEARISH $HIMS"
Well, not quite...
The FDA did a couple things today that point in opposite directions.
The FDA's briefing doc proposes all 7 peptides NOT be added to the 503A bulks list. Not on that list = pharmacies can't legally compound them. Yep, bad for $HIMS.
This definitely wasn't the ideal case for "team peptides". But it also wasn't a huge surprise. Needham said last week that something like this could very well happen -- after all, the FDA has been skeptical on peptides for years (it literally "banned" them in 2023). Needham said it expects a majority of peptides to be reclassified, but hedged that "the FDA's prior actions suggest a cautious stance toward several of the peptides under review."
But wait. There's more. Today we also learned that HHS has completely stacked the bench in favor of "team peptides".
Previously the PCAC committee had only 3-4 voting members and no chair. Now it has 8 new panelists, most tied to businesses that prescribe/promote peptides, including Bobby Harshbarger (whose mother, Diana Harshbarger, formally lobbied the FDA to ease peptide rules last year).
Historically, the PCAC panel has been happy to go along with whatever recommendations the FDA staff makes.
Stacking it with peptide bulls means HHS is pushing to break that pattern.
So now July 23-24 is the whole ballgame. Old-guard FDA staff vs. an RFK-built panel with a mandate to overrule them.
Of course FDA doesn't want peptides approved.
Why would they want cheap, off-patent compounds in the hands of normal people?
That would mean people recover faster, carry less pain, are leaner and stronger, and avoid more downstream comorbidities.
Most importantly, people become harder to monetize as lifelong patients.
I'm not surprised the FDA’s current position is that BPC-157, TB-500, MOTS-c, Semax, Epitalon and the rest should stay off the 503A Bulks List.
How can they profit off of you then?
A healthier, stronger, and in the end, sovereign population is not good for the sick-care system.
They’ll call it safety and say they’re protecting you, but the truth is, your health was never in their best interest.
@peptidepirate Kisspeptin is extremely underrated and hardly ever mentioned. I considered TRT at first but kiss ended up doubling my testosterone in 2 months.
@Cernovich 3mg Reta, 2mg Tesamorelin/300mcg Ipamorelin, 20mg KLOW, 4mg MOTS-C, 600mcg Kisspeptin. Kiss and MOTS every other day. Reta only once a week, the rest daily.